Skip to main content

Advertisement

Log in

Rheumatoid arthritis

How does citrullination contribute to RA autoantibody development?

  • News & Views
  • Published:

From Nature Reviews Rheumatology

View current issue Sign up to alerts

The onset of the destructive autoimmune joint disease rheumatoid arthritis (RA) is preceded by the development of autoantibodies to multiple citrullinated proteins. Research has now shown that citrullination modifies antigen processing, resulting in the production of cryptic epitopes, suggesting a new model for RA autoantibody development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Curran, A. M. et al. Citrullination modulates antigen processing and presentation by revealing cryptic epitopes in rheumatoid arthritis. Nat. Commun. 14, 1061 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Gregersen, P. K., Silver, J. & Winchester, R. J. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 30, 1205–1213 (1987).

    Article  CAS  PubMed  Google Scholar 

  3. Lo, K. C. et al. Comprehensive profiling of the rheumatoid arthritis antibody repertoire. Arthritis Rheumatol. 72, 242–250 (2020).

    Article  CAS  PubMed  Google Scholar 

  4. Hill, J. A. et al. Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J. Immunol. 171, 538–541 (2003).

    Article  CAS  PubMed  Google Scholar 

  5. Auger, I. et al. Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrinogen. Arthritis Rheum. 52, 3424–3432 (2005).

    Article  CAS  PubMed  Google Scholar 

  6. Sidney, J. et al. Citrullination only infrequently impacts peptide binding to HLA class II MHC. PLoS One 12, e0177140 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  7. Auger, I., Martin, M., Balandraud, N. & Roudier, J. Rheumatoid arthritis-specific autoantibodies to peptidyl arginine deiminase type 4 inhibit citrullination of fibrinogen. Arthritis Rheum. 62, 126–131 (2010).

    Article  CAS  PubMed  Google Scholar 

  8. Arnoux, F. et al. Peptidyl arginine deiminase immunization induces anticitrullinated protein antibodies in mice with particular MHC types. Proc. Natl Acad. Sci. USA 114, E10169–E10177 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Auger, I. et al. Peptidylarginine deiminase autoimmunity and the development of anti-citrullinated protein antibody in rheumatoid arthritis: the hapten-carrier model. Arthritis Rheumatol. 72, 903–911 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Balandraud, N., Auger, I. & Roudier, J. Do RA associated HLA-DR molecules bind citrullinated peptides or peptides from PAD4 to help the development of RA specific antibodies to citrullinated proteins? J. Autoimmun. 116, 102542 (2021).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jean Roudier.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Roudier, J., Auger, I. How does citrullination contribute to RA autoantibody development?. Nat Rev Rheumatol 19, 329–330 (2023). https://doi.org/10.1038/s41584-023-00959-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41584-023-00959-9

  • Springer Nature Limited

Navigation